Literature DB >> 2545324

The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system.

M Suzuki1, T Takahashi, K Ouchi, S Matsuno.   

Abstract

Computer-assisted three-dimensional (3D) reconstruction of the biliary tree including extrahepatic and intrahepatic parts was performed from surgical or autopsy materials from 12 patients with hepatohilar bile duct carcinoma in an effort to visualize three-dimensionally the distribution of carcinoma and dysplasia. In each case, material including a hepatic lobe was reduced to serial slices 1 mm thick using a ham slicer, then the tumors, ducts with carcinoma in situ, and those with dysplasia were submitted to reconstruction. In a 3D map of biliary tree reproduced on a display, a dysplastic zone was shown in most cases surrounding a focus of carcinoma, justifying the assumption of a dysplasia-carcinoma sequence. The carcinoma itself proved to form multiple foci along bile ducts in as many as 42% of the patients, in some of whom the foci were independent without any intervening dysplasia. These results suggest that as extensive a surgical measure as possible should be taken in designing a strategy against this tumor.

Entities:  

Mesh:

Year:  1989        PMID: 2545324     DOI: 10.1002/1097-0142(19890801)64:3<658::aid-cncr2820640316>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Authors:  S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Authors:  J C Flickinger; A H Epstein; S Iwatsuki; B I Carr; T E Starzl
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

4.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

5.  CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma.

Authors:  Baek-hui Kim; Nam-Yun Cho; So Hyun Shin; Hyeong-Ju Kwon; Ja June Jang; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2009-09-10       Impact factor: 4.064

6.  Prognostic factors in hilar cholangiocarcinoma.

Authors:  M Sahin
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

7.  Contrast-enhanced ultrasound in diagnosis and characterization of focal hepatic lesions.

Authors:  Inés Gómez Molins; Juan Manuel Fernández Font; Juan Carrero Alvaro; Jose Luís Lledó Navarro; Marta Fernández Gil; Conrado M Fernández Rodríguez
Journal:  World J Radiol       Date:  2010-12-28

8.  Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution.

Authors:  Alfred Wei-Chieh Kow; Choi Dong Wook; Sun Choon Song; Woo Seok Kim; Min Jung Kim; Hyo Jun Park; Jin Soek Heo; Seong Ho Choi
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

9.  Thermo-chemo-radiotherapy for advanced bile duct carcinoma.

Authors:  Terumi Kamisawa; Yuyang Tu; Naoto Egawa; Katsuyuki Karasawa; Tadayoshi Matsuda; Kouji Tsuruta; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 10.  Hepatopancreatoduodenectomy for anastomotic recurrence from residual cholangiocarcinoma: report of a case.

Authors:  Seiji Natsume; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Masato Nagino
Journal:  Surg Today       Date:  2013-05-24       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.